Anticancer agent 162

• UNSPSC Description:

  Anticancer agent 162 (compound 1d) is an effective anticancer theranostic agent. Anticancer agent 162 induces oncosis of Hela cells with lipophilicity and cytotoxicity selectivity[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-162.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=S([O-])(C(F)(F)F)=O.C1(N=C(C2=C(C3=[N]([Pt+2]45[C-]6=C(C7=[N]5C=CC=C7)C=CC=C6)C=CC=C38)[N]4=CC=C2)C8=N9)=C9C=CC=C1

• Molecular Weight:

  780.64

• References & Citations:

  [1]Wang W, et al. A Series of Planar Phosphorescent Cyclometalated Platinum(II) Complexes as New Anticancer Theranostic Agents That Induce Oncosis. J Med Chem. 2023 Sep 28;66(18):13103-13115.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4